Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Novalead Pharma Private Limited.
Recruitment status was  Not yet recruiting
Study NCT01113515   Information provided by Novalead Pharma Private Limited

First Received on April 28, 2010.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Foot Ulcer
Additional conditions recognized in this trial
Diabetic Foot
Foot Ulcer
Ulcer
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Diabetic Angiopathies
Diabetic Neuropathies
Endocrine System Diseases
Foot Diseases
Leg Ulcer
Pathologic Processes
Skin Diseases
Skin Ulcer
Vascular Diseases
Interventions listed in this trial
Esmolol hydrochloride
Placebo gel
Additional drug interventions recognized in this trial
Esmolol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Novalead Pharma Private Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services